Articles On LBT Innovations (ASX:LBT)

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Adelaide-based minnow LBT Innovations is ready to sell its automated agar plate interpretation device to the world – or, more ... Read More The post Dr Boreham’s Crucible: LBT Innovations has one product – but at least it’s on the market ap...

Australian medical technology company LBT Innovations (ASX:LBT) has announced the sale of an APAS Independence with MRSA analysis module to the Limbach Group based in Germany.

AI-based biotechnology company LBT Innovations has landed a sale in Europe for its APAS Independence platform. ... Read More The post LBT Innovations lands European sales deal for AI-based laboratory tech appeared first on Stockhead.

ShareCafeLBT Innovations – Hidden Gems Webinar Presentation   Presenter – Brent Barnes – CEO & MD – LBT Innovations improves patient outcomes by making healthcare more efficient. Based in Adelaide, South Australia, the Company has a hi...

ShareCafeHidden Gems Webinar Recap – LBT, ADN, NYR, SPT   Catch up on the full webinar with presentations from LBT Innovations Ltd (ASX:LBT), Andromeda Metals Ltd (ASX:ADN), Nyrada Inc (ASX: NYR) and Splitit Ltd (ASX:SPT). Hidden Gems Webi...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week We’re coming...

ASX companies continued to raise money in July, with over $4bn shelled out by investors, taking 2020’s total above $30bn. According to Bloomberg, there has been $32.3bn worth of cash raised between January 1 and August 3. This is well ahead...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The market...

A month away from hitting the ASX, 4DMedical has its sights set on the United States and its spiralling COVID-19 situation as a target market for its lung imaging technology. The Australian medtech is developing a patented X-ray imaging pla...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The life s...

ASX-listed biotech LBT Innovations has inked an agreement with an American medical testing company - and now wants fresh funds to help make the most of it. 

Fresh off its first sale in the US and positive results from a John Hopkins School of Medicine study, LBT Innovations (ASX:LBT) shares are set to rise again following a European marketing deal. The Adelaide company makes automated microbiol...

Australian medical technology company LBT Innovations (ASX: LBT) has signed a marketing agreement with clinical diagnostics specialist Beckman Coulter for the sale of its culture-plate screening and interpretation technology throughout Euro...

A quick wrap of the key winners and losers on Wednesday, July 1. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 874 stocks rose, 463 declined and 776 wer...

The LBT Innovations Limited (ASX: LBT) share price is storming higher today after the company announced the achievement of a milestone in the United States. At the time of writing, LBT Innovations shares last changed hands at 15.5 cents, r...

Australian medical technology company LBT Innovations (ASX:LBT) has updated investors on its 510(k) submission to the US FDA for the APAS Independence with MRSA analysis module.

Australian medical technology company LBT Innovations (ASX LBT) has announced the submission of a 510(k) application to the US FDA for the APAS Independence inclusive with the MRSA analysis module as a Class 2 medical device.

Technology with excellent innovation potential is Artificial Intelligence (AI), which is gaining ubiquitous applicability in multiple industries like a flash. Lately, Innovation and Science Australia (ISA) also recommended prioritising inve...

Here’s our fortnightly wrap of the major small cap health stock winners and losers.  One small cap ASX healthcare company has stormed home to top the tables at the end of October. Novita Healthcare (ASX:NHL) shares have exploded 500 per cen...

LBT Innovations Limited (ASX: LBT)- the Australian medical technology company secured its first sales for its APAS® Independence instrument in the European Union. The company sold the APAS® Independence instrument to Labor Dr Wisplinghoff...

Australian medical technology company LBT Innovations (ASX: LBT) has announced the first sale of its APAS (Automatic Plate Assessment System) Independence instrument within the European Union, to Germany’s largest clinical laboratory Labor...

The 10th Annual Australian Microcap Investment Conference will be held on Tuesday 22 October 2019 over two days at the Sofitel Melbourne on Collins. The Conference is Australia’s largest and most comprehensive emerging company investment ev...

Medical technology company LBT Innovations (ASX: LBT) is set to take its artificial intelligence-inspired APAS Independence instrument to Europe after obtaining the highly prized CE Mark certification – a stamp of regulatory approval issued...

The sales focus in Australia continues to be private-sector laboratories as public laboratories remain challenging with no new tenders expected in 2019.

A company may require more funds over and above its retained earnings in order to expand its existing operations, develop new businesses, protect market share or buy another company. The requirement of the company can be fulfilled by either...

At Stockhead we are as amazed as our readers when stocks rise by over 100 per cent in a day. But its a more common occurrence than we thought. There have been 23 stocks that have achieved that feat. The three most common reasons are success...

This second drawdown, together with the cash on hand following a recent $5 million placement, means the company is well funded into 2021.